• Events
  • BIOPLUS INTERPHEX Korea 2025 x KACTUS

    Sep 24, 2025

    KACTUS is excited to share that we will be participating in BIOPLUS INTERPHEX (BIX) Korea 2025, taking place from October 15 to 17, 2025 at COEX in Seoul. Recognized as one of Asia’s leading bio-pharmaceutical business platforms, this event brings together innovators from every corner of the biopharma value chain.

    What are BioPlus and Interphex?

    BIOPLUS-INTERPHEX Korea is a leading exhibition that brings together global biopharmaceutical professionals to explore the latest advances in drug development and manufacturing. The event covers the entire value chain, including biopharma R&D, process development, manufacturing technologies, quality control, digital health, packaging, and cold-chain logistics. With its combination of large-scale exhibition, international conference sessions, and partnering programs, BIOPLUS-INTERPHEX Korea serves as a comprehensive hub for innovation, collaboration, and business development in the global bio-industry.

    Event Overview 

    Venue: COEX, Hall C (3F) & Conference Rooms, Seoul, Korea

    Dates: October 15th to 17th 2025

    • Conference Day 1: Wednesday, October 15, 2025 – 9:30 AM to 4:45 PM

    • Conference Day 2: Thursday, October 16, 2025 – 9:00 AM to 4:45 PM

    • Conference Day 3: Friday, October 17, 2025 – 9:00 AM to 3:15 PM

    Booth #F06

    Event Schedule 

    BIX highlights the latest innovations in biopharmaceuticals. Over three days at COEX Seoul, the event delivers keynote talks, technical sessions, and networking focused on drug discovery, manufacturing, quality control, digital health, and regenerative medicine. Explore the full agenda to see what’s ahead.

    Day 1: Wednesday, October 15, 2025

    Time

    Session Type

    Title

    9:00 – 9:30 AM

    Registration

    Registration

    9:30 – 10:00 AM

    Opening Ceremony

    Opening Ceremony

    10:15 – 10:45 AM

    Keynote Session

    The Role of Cellular and Regenerative Medicine in Longevity and Human Performance

    11:00 – 12:00 PM

    Technical Session 01

    Ready to Jump Off the Patent Cliff? A Global Perspective on Biopharma’s Hunt for the Next Blockbusters

    11:00 – 12:00 PM

    Technical Session 02

    How FDA’s New Rules Are Reshaping the Future of Global Biotech

    12:00 – 1:00 PM

    Luncheon Session 01

    Luncheon Session

    1:00 – 2:00 PM

    Technical Session 03

    Anti-Aging: The Next Bio Frontier? Challenges and Strategies in Science, Regulation, and the Market

    1:00 – 2:00 PM

    Technical Session 04

    Biotech’s ESG Disclosure Gap: How Prepared Are We?

    2:15 – 2:45 PM

    Insight Session 01

    Insight on Regulatory Innovation

    2:15 – 2:45 PM

    Insight Session 02

    Insight on Regulatory Pathways

    3:00 – 3:30 PM

    Insight Session 03

    Insight on Clinical Data and Real-World Evidence

    3:00 – 3:30 PM

    Insight Session 04

    Insight on Global Regulatory Trends

    3:45 – 4:45 PM

    Technical Session 05

    NewCo: Just a Spin-Off or an Innovative Business Structure?

    3:45 – 4:45 PM

    Technical Session 06

    Building Cross-Border Commercialization Pathways


    Day 2: Thursday, October 16, 2025

    Time

    Session Type

    Title

    9:00 – 10:00 AM

    Featured Session

    The Transformation of Health by Technology

    9:00 – 10:00 AM

    Technical Session 07

    Next-Generation WhiteBio Business Model: Carbon Circulation Platform

    9:00 – 10:00 AM

    Technical Session 08

    US Industry Insights for Korea’s Global Leap

    10:15 – 10:45 AM

    Insight Session 05

    Technology Insight

    10:15 – 10:45 AM

    Insight Session 06

    Technology Innovation

    11:00 – 12:00 PM

    Technical Session 09

    Accelerating ADC Globalization: Trends, Challenges, and Strategic Collaborations

    11:00 – 12:00 PM

    Technical Session 10

    Innovation Driven Drug Discovery in Real Fields

    12:00 – 1:00 PM

    Luncheon Session 02

    Luncheon Session

    1:00 – 2:00 PM

    Technical Session 11

    Radiopharma Revolution: Unmet Needs, Innovation, and Global Access

    1:00 – 2:00 PM

    Technical Session 12

    Global Pharma Cold Chain Innovation: GDP Compliance and Sustainable Logistics

    2:15 – 2:45 PM

    Insight Session 07

    Technology Breakthroughs in Biopharma

    2:15 – 2:45 PM

    Insight Session 08

    Technology for Next-Gen Biologics

    3:00 – 3:30 PM

    Insight Session 09

    Technology Strategies for Global Expansion

    3:00 – 3:30 PM

    Insight Session 10

    Technology Solutions for Bio Logistics

    3:45 – 4:45 PM

    Insight Session 11

    KOSDAQ Listing Strategies for Bio Companies: Deep Dive into Special Technology Listing Track

    3:45 – 4:45 PM

    Technical Session 13

    Connecting the Korea-Japan Bio Ecosystem: Strategies for Open Innovation


    Day 3: Friday, October 17, 2025

    Time

    Session Type

    Title

    9:00 – 10:00 AM

    Technical Session 14

    China Biotech’s “Deepseek” Moment Is Coming. Are You Ready?

    9:00 – 10:00 AM

    Technical Session 15

    Navigating Future Growth through Biotech M&A

    10:15 – 10:45 AM

    Insight Session 12

    Global Biotech Manufacturing Trends

    11:00 – 12:00 PM

    Technical Session 16

    Emerging Trends in Bio Materials, Equipment, Cold Chain, and AI Applications

    12:00 – 1:50 PM

    Docent Tour

    New Drug Development, Cold Chain, and Lab Equipment

    2:15 – 3:15 PM

    Technical Session 17

    Licensing-Out Strategies for K-Bio: Unlocking Global Opportunities

     

    About KACTUS

    KACTUS excels in crafting and producing an array of superior-grade, highly active recombinant proteins and enzymes, catering to diverse sectors like antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. Our expansive catalog, boasting over 2500 recombinant proteins, encompasses a wide spectrum of targets, species, tags, and labels, each thoughtfully chosen to address the specific, unmet needs of scientists engaged in drug development. The hallmark of our product selection process is a rigorous emphasis on exceptional quality and a steadfast commitment to ensuring reliable supply, thereby upholding the highest standards of excellence and client satisfaction.

    Featured Products 

    MHC Monomers & Tetramers

    Transmembrane Proteins 

    Custom Proteins and Expressions

     


    More from > Events